News

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The US Food and Drug Administration will require all new vaccines go through placebo-controlled studies before they are ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
The unusual move at FDA comes shortly after the agency's longtime vaccine chief was forced out over disagreements with Makary ...
Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.
FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.
As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...
Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...
Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine after the agency grants full approval. The company said it had responded ...
The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a closer look at whether to approve boosters for this winter.